financetom
Business
financetom
/
Business
/
Western Union Q3 profit beats on Travel Money unit expansion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Western Union Q3 profit beats on Travel Money unit expansion
Oct 23, 2025 1:38 PM

Overview

* Western Union ( WU ) Q3 revenue flat at $1.03 bln, beating analyst expectations

* Adjusted EPS for Q3 beats consensus at $0.47, benefiting from cost efficiencies

* Consumer Services revenue grew 49%, driven by Travel Money expansion

Outlook

* Company expects 2025 GAAP revenue between $4.085 bln and $4.185 bln

* Western Union ( WU ) projects 2025 adjusted revenue between $4.035 bln and $4.135 bln

* Company forecasts 2025 GAAP EPS between $1.45 and $1.55

* Western Union ( WU ) expects 2025 adjusted EPS between $1.65 and $1.75

Result Drivers

* CONSUMER SERVICES GROWTH - Revenue increased 49% due to Travel Money expansion and Eurochange acquisition

* BRANDED DIGITAL GROWTH - Revenue grew 7% with a 12% increase in transactions

* CMT DECLINE - Revenue fell 6% due to North America retail slowdown

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $1.03 $1.02

Revenue bln bln (13

Analysts

)

Q3 Beat $0.47 $0.43

Adjusted (15

EPS Analysts

)

Q3 EPS $0.43

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 11 "hold" and 6 "sell" or "strong sell"

* The average consensus recommendation for the business support services peer group is "buy."

* Wall Street's median 12-month price target for Western Union Co ( WU ) is $9.00, about 9.7% above its October 21 closing price of $8.13

* The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 5 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
National Bank and Canadian Western Bank Announced CWB Tier 1 Capital Reorganization
National Bank and Canadian Western Bank Announced CWB Tier 1 Capital Reorganization
Oct 17, 2024
05:57 AM EDT, 10/17/2024 (MT Newswires) -- National Bank of Canada ( NTIOF ) and Canadian Western Bank ( CWESF ) announced overnight Wednesday a planned reorganization of CWB's tier 1 capital in the context of the previously announced proposed acquisition of all of the common shares of CWB by National Bank. A statement noted the proposed amendments will permit...
BRIEF-Eni's sale of biofuel unit stake to KKR expected by year-end, CEO says
BRIEF-Eni's sale of biofuel unit stake to KKR expected by year-end, CEO says
Oct 17, 2024
Oct 17 (Reuters) - Eni Chief Executive Claudio Descalzi tells reporters on the sidelines of an event in Milan : * WILL CLOSE BY YEAR END SALE OF STAKE IN ENILIVE TO KKR * FALL IN OIL PRICES IMPACTING MARGINS, BUT LESS THAN IN THE PAST THANKS TO DIVERSIFICATION Further company coverage: (Reporting by Milan newsroom) ...
Verastem Reports Updated Data on Phase 2 Study of Ovarian Cancer Combination Therapy
Verastem Reports Updated Data on Phase 2 Study of Ovarian Cancer Combination Therapy
Oct 17, 2024
05:18 AM EDT, 10/17/2024 (MT Newswires) -- Verastem Oncology (VSTM) said Thursday that updated data from a phase 2 study evaluating the combination of avutometinib and defactinib in patients with recurrent low-grade serous ovarian cancer demonstrated robust overall response rates. The company said all evaluable patients with measurable disease showed a confirmed overall response rate of 31%, with about 12...
--Gritstone bio Slumps Premarket After Disclosing 19% Reduction in Workforce
--Gritstone bio Slumps Premarket After Disclosing 19% Reduction in Workforce
Oct 17, 2024
05:26 AM EDT, 10/17/2024 (MT Newswires) -- Price: 0.0549, Change: -0.01, Percent Change: -17.00 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved